| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-12 00:03:26 UTC |
|---|
| Updated at | 2022-09-12 00:03:26 UTC |
|---|
| NP-MRD ID | NP0321702 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (2s,3s)-n-[(s)-[(4r,6r)-6-[(2s,3r)-3-[(3s)-6,8-dihydroxy-5-methyl-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxan-2-yl](methoxy)methyl]-2-hydroxy-3-methoxy-5-methylhex-5-enimidic acid |
|---|
| Description | IRCINIASTATIN belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. Hydroxybenzoic acid derivatives are compounds containing a hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxyl and a hydroxyl groups. (2s,3s)-n-[(s)-[(4r,6r)-6-[(2s,3r)-3-[(3s)-6,8-dihydroxy-5-methyl-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxan-2-yl](methoxy)methyl]-2-hydroxy-3-methoxy-5-methylhex-5-enimidic acid was first documented in 2015 (PMID: 26544018). Based on a literature review a small amount of articles have been published on IRCINIASTATIN (PMID: 31063392) (PMID: 26879056) (PMID: 26027837). |
|---|
| Structure | CO[C@@H](CC(C)=C)[C@H](O)C(O)=N[C@@H](OC)C1C[C@@H](O)C(C)(C)[C@@H](C[C@H](O)[C@@H](C)[C@@H]2CC3=C(C)C(O)=CC(O)=C3C(=O)O2)O1 InChI=1S/C31H47NO11/c1-14(2)9-22(40-7)27(37)28(38)32-29(41-8)23-13-24(36)31(5,6)25(42-23)12-19(34)16(4)21-10-17-15(3)18(33)11-20(35)26(17)30(39)43-21/h11,16,19,21-25,27,29,33-37H,1,9-10,12-13H2,2-8H3,(H,32,38)/t16-,19+,21+,22+,23?,24-,25-,27+,29+/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C31H47NO11 |
|---|
| Average Mass | 609.7130 Da |
|---|
| Monoisotopic Mass | 609.31491 Da |
|---|
| IUPAC Name | (2S,3S)-N-[(S)-[(4R,6R)-6-[(2S,3R)-3-[(3S)-6,8-dihydroxy-5-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxan-2-yl](methoxy)methyl]-2-hydroxy-3-methoxy-5-methylhex-5-enimidic acid |
|---|
| Traditional Name | (2S,3S)-N-[(S)-[(4R,6R)-6-[(2S,3R)-3-[(3S)-6,8-dihydroxy-5-methyl-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-2-hydroxybutyl]-4-hydroxy-5,5-dimethyloxan-2-yl](methoxy)methyl]-2-hydroxy-3-methoxy-5-methylhex-5-enimidic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CO[C@@H](CC(C)=C)[C@H](O)C(O)=N[C@@H](OC)C1C[C@@H](O)C(C)(C)[C@@H](C[C@H](O)[C@@H](C)[C@@H]2CC3=C(C)C(O)=CC(O)=C3C(=O)O2)O1 |
|---|
| InChI Identifier | InChI=1S/C31H47NO11/c1-14(2)9-22(40-7)27(37)28(38)32-29(41-8)23-13-24(36)31(5,6)25(42-23)12-19(34)16(4)21-10-17-15(3)18(33)11-20(35)26(17)30(39)43-21/h11,16,19,21-25,27,29,33-37H,1,9-10,12-13H2,2-8H3,(H,32,38)/t16-,19+,21+,22+,23?,24-,25-,27+,29+/m1/s1 |
|---|
| InChI Key | BNNIEBYABSNREN-FKNVEFDBSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hydroxybenzoic acid derivatives. Hydroxybenzoic acid derivatives are compounds containing a hydroxybenzoic acid (or a derivative), which is a benzene ring bearing a carboxyl and a hydroxyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | Hydroxybenzoic acid derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dihydroxybenzoic acid
- Benzopyran
- Isochromane
- 2-benzopyran
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Fatty amide
- Monosaccharide
- Fatty acyl
- N-acyl-amine
- Oxane
- Vinylogous acid
- Carboxamide group
- Carboxylic acid ester
- Lactone
- Secondary carboxylic acid amide
- Secondary alcohol
- Oxacycle
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Alcohol
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Yu J, Yang M, Guo Y, Ye T: Total Synthesis of Psymberin (Irciniastatin A). Org Lett. 2019 May 17;21(10):3670-3673. doi: 10.1021/acs.orglett.9b01113. Epub 2019 May 7. [PubMed:31063392 ]
- Liu Q, An C, TenDyke K, Cheng H, Shen YY, Hoye AT, Smith AB 3rd: Design, Synthesis, and Evaluation of Irciniastatin Analogues: Simplification of the Tetrahydropyran Core and the C(11) Substituents. J Org Chem. 2016 Mar 4;81(5):1930-42. doi: 10.1021/acs.joc.5b02771. Epub 2016 Feb 16. [PubMed:26879056 ]
- Uesugi S, Watanabe T, Imaizumi T, Ota Y, Yoshida K, Ebisu H, Chinen T, Nagumo Y, Shibuya M, Kanoh N, Usui T, Iwabuchi Y: Total Synthesis and Biological Evaluation of Irciniastatin A (a.k.a. Psymberin) and Irciniastatin B. J Org Chem. 2015 Dec 18;80(24):12333-50. doi: 10.1021/acs.joc.5b02256. Epub 2015 Nov 16. [PubMed:26544018 ]
- Quach HT, Hirano S, Fukuhara S, Watanabe T, Kanoh N, Iwabuchi Y, Usui T, Kataoka T: Irciniastatin A induces potent and sustained activation of extracellular signal-regulated kinase and thereby promotes ectodomain shedding of tumor necrosis factor receptor 1 in human lung carcinoma A549 cells. Biol Pharm Bull. 2015;38(6):941-6. doi: 10.1248/bpb.b15-00078. [PubMed:26027837 ]
- LOTUS database [Link]
|
|---|